Posted by Dr. Mercola | April 17 201
In an important OpEd piece from the Washington Examiner, Barbara Hollingsworth sets the record straight about Gardasil:
“Cervical cancer accounts for less than 1 percent of all cancer deaths — so it was somewhat surprising when the U.S. Food and Drug Administration fast-tracked approval of Gardasil, a Merck vaccine targeting the human papilloma virus that causes the disease.
As of the end of January 2010, 49 unexplained deaths following Gardasil injections have been reported to the Centers for Disease Control and Prevention’s Vaccine Adverse Event Reporting System. By contrast, 52 deaths are attributed to unintended acceleration in Toyotas, which triggered a $2 billion recall.”
There has been no recall for Gardasil, however. In fact, as Hollingsworth points out, it is required for sixth-grade girls in D.C., Maryland, Virginia, and many other states.
Unfortunately, “Merck denies any of the deaths are related to its vaccine, and the parents involved can’t prove they were,” Hollingsworth writes.
India Suspends Gardasil!
Unlike in the United States, The Indian Council of Medical Research (ICMR) has told two Indian states, Andhra Pradesh and Gujarat, to halt its Gardasil vaccine study, which was slated to test the vaccine in about 32,000 girls between the ages of 10 and 14.
DNA India reports:
“The program is part of a two-year study to look into the utility of a vaccine in public health programs and acceptability of Gardasil.
The program was marred by controversy after four deaths and complications among 120 girls were reported after vaccination. The girls complained of stomach disorders, epilepsy, headaches and early menarche.”
Dr. Mercola’s Comments
It is indeed suspicious that the FDA put Gardasil on a fast-tracked approval process. What many people fail to appreciate is that the human papilloma virus is a sexually transmitted disease, not a virus you can get by shaking someone’s hand.
Further, they were surely well aware that at least 50 percent of sexually active men and women acquire genital HPV infection at some point in their lives — and 90 percent of the time the virus clears up on its own within two years, and does not lead to cancer.
Why Are We Wasting Our Resources on this Vaccine?
Cervical cancer is just not that common to begin with. There were just over 11,000 new cases diagnosed in 2009, and about 4,000 women died of the disease that year, according to the American Cancer Society.
Cervical cancer killed 12 times fewer people in 2009 than did hospital-acquired infections … yet the FDA chose to fast-track the Gardasil vaccine? It just doesn’t add up.
That is a TOTAL of 4,000 deaths in the US for the year. While even one death is tragic, it is important to keep these numbers in perspective. All this time, effort and energy is being invested to save 4,000 lives.
This entire program is being initiated with virtually no long-term safety studies or effectiveness rates.